TABLE 2.

Risk of macro- and microvascular complications in different clusters in long-term adult diabetes relative to MARD.

Complications	SAID		SIDD		IROD1		IROD2
	OR (95% CI)	P-value	OR (95% CI)	P-value	OR (95% CI)	P-value	OR (95% CI)	P-value
PDR	9.32 (2.15, 40.46)	0.003*	2.42 (0.96, 6.07)	0.06	0.53 (0.16, 1.79)	0.31	0.73 (0.23, 2.32)	0.59
CKD	2.59 (1.34, 5.00)	0.005*	2.03 (1.21, 3.40)	7.1 × 10–3*	1.63 (1.08, 2.46)	0.02*	0.85 (0.53, 1.39)	0.52
Neuropathy	3.30 (1.29, 8.43)	0.01*	13.60 (5.20, 35.50)	1.0 × 10–7*	2.08 (1.28, 3.37)	3.0 × 10–3*	0.70 (0.45, 1.09)	0.12
CVD	0.61 (0.25, 1.51)	0.3	1.13 (0.60, 2.11)	0.71	1.11 (0.68, 1.8)	0.68	1.44 (0.87, 2.36)	0.15

PDR, proliferative diabetic retinopathy; CKD, chronic kidney disease; CVD, cardiovascular disease; OR, Odds Ratios; 95% CI, 95% confidence intervals; and p-values were calculated using logistic regression adjusted for sex, age, and diabetes duration. *Significant after adjustment for the multiple testing using FDR (<0.05).